CareCloud 配当と自社株買い
配当金 基準チェック /06
CareCloud配当金を支払った記録がありません。
主要情報
n/a
配当利回り
0.003%
バイバック利回り
| 総株主利回り | 0.003% |
| 将来の配当利回り | n/a |
| 配当成長 | n/a |
| 次回配当支払日 | n/a |
| 配当落ち日 | n/a |
| 一株当たり配当金 | n/a |
| 配当性向 | n/a |
最近の配当と自社株買いの更新
Recent updates
CCLD: Clearer Organic Revenue Trends Will Support Future Upside Potential
Analysts have trimmed their average price target on CareCloud to $3.25, citing concerns that recent acquisitions, including a planned aircraft purchase, are masking underlying revenue declines and adding nonessential spending to the story. Analyst Commentary Bullish analysts are weighing CareCloud's recent moves against concerns around revenue trends and spending, and are looking closely at how management deploys capital from acquisitions and new initiatives.The CareCloud, Inc. (NASDAQ:CCLD) First-Quarter Results Are Out And Analysts Have Published New Forecasts
There's been a notable change in appetite for CareCloud, Inc. ( NASDAQ:CCLD ) shares in the week since its quarterly...CCLD: Capital Discipline And AI Adoption Will Drive Future Repricing Confidence
Analysts have adjusted their price target on CareCloud to $6.31, citing concerns that acquisitive activity and plans for an aircraft purchase may be obscuring underlying revenue softness and creating questions around capital allocation discipline. Analyst Commentary Analyst commentary around CareCloud centers on how acquisitions and capital allocation choices, including the planned aircraft purchase, may influence the company’s ability to deliver consistent execution and support the current valuation.CCLD: Cost Controls And AI Automation Will Offset Acquisition And Aircraft Spending
Analysts have reaffirmed their $3.25 price target on CareCloud, citing recent results as reasonable. However, they expressed concern that acquisitions, including a planned aircraft purchase for client visits, may be obscuring the company’s underlying revenue trends.CCLD: Clearer Organic Revenue Disclosure Will Support Future Upside Potential
Narrative Update on CareCloud Analysts have reduced their CareCloud price target to $3.25, reflecting concerns that recent acquisitions and the planned aircraft purchase may be masking underlying revenue declines rather than supporting a stronger long term outlook. Analyst Commentary Recent commentary points to a cautious stance on CareCloud, with the current US$3.25 price target described as reflecting concern that acquisitions and the planned aircraft purchase may be masking underlying revenue pressure rather than supporting a clearer long term growth story.CCLD: Higher Margins And New Contracts Will Support Future Upside
Analysts have trimmed CareCloud's price target to $3.25. This reflects concerns that acquisitive activity, including the planned aircraft purchase, is obscuring underlying revenue softness, even as profit margin assumptions improve and future P/E expectations reset lower.CCLD: Supply Chain And Urgent Care Expansion Will Support Future Upside
Analysts have adjusted their CareCloud price target to reflect updated assumptions on discount rate, revenue growth, profit margin, and future P/E. This has led to a revised view of the potential upside for the shares.CCLD: Cost Controls And AI Automation Will Drive Future Repricing Potential
Analysts have updated their view on CareCloud with a revised $3.25 price target, citing refreshed assumptions for revenue growth, profit margins, discount rate and future P/E, while also pointing to recent Street research, including new coverage with an $8 target, as context for the valuation range. Analyst Commentary The refreshed $3.25 target sits well below the new $8 initiation level referenced in Street research, which highlights how split opinions are around CareCloud’s execution and valuation.Take Care Before Diving Into The Deep End On CareCloud, Inc. (NASDAQ:CCLD)
You may think that with a price-to-sales (or "P/S") ratio of 0.9x CareCloud, Inc. ( NASDAQ:CCLD ) is a stock worth...CCLD: Cost Discipline And AI Rollout Will Support Future Rerating Potential
Analysts have nudged their price target for CareCloud higher, with some recent research pointing to a range up to US$8. This reflects revised assumptions for cost controls, a flatter near term revenue and EBITDA outlook, and a higher future P/E multiple in their models.CareCloud: Undervalued AI Play In Healthcare IT
Summary CareCloud is transitioning from an RCM provider to AI-driven healthcare IT, targeting higher-margin recurring revenues. I assign CCLD a buy rating with a 1-year price target of $4.3, implying 48% upside from $2.9. Recent performance shows six consecutive quarters of GAAP profitability, strong cost control, and solid operating cash flow. Key risks include 2026 state AI regulations, which may limit adoption of CCLD’s new AI voice solutions. Read the full article on Seeking AlphaCCLD: Cost Controls And AI Automation Will Support Future Repricing
Analysts have adjusted their price target on CareCloud to $3.25 based on updated views of revenue growth, profit margins, cost controls, and long-term P/E assumptions following recent research, including new coverage with an $8 target and revised estimates after the latest Q3 report. Analyst Commentary Recent research on CareCloud reflects a mix of optimism and restraint, with one firm starting coverage at a higher price target and others resetting expectations closer to current fundamentals.CCLD: Cost Controls And New AI Offering Will Support Future Upside
Narrative Update on CareCloud Analysts have lifted their price target on CareCloud to $3.25 from $2.25, citing updated forecasts for revenue growth, a different margin profile, a higher assumed future P/E multiple, and recent Street research that includes new coverage and refreshed estimates following the Q3 report. Analyst Commentary Recent Street research on CareCloud offers a mixed picture, with some upbeat coverage alongside more cautious views.CCLD: Cost Controls And EBITDA Durability Will Drive Shares Higher
Analysts have raised their price target on CareCloud to $8.00 from prior levels near $3.25, citing new Buy-rated coverage and expectations that tighter cost controls will support near term EBITDA even as revenue growth moderates. Analyst Commentary Bullish analysts point to recent price target increases as evidence that the market may be underestimating CareCloud's ability to sustain profitability while navigating slower top line growth.CCLD: Improved Cost Controls Will Sustain Near-Term Profitability Momentum
CareCloud's analyst price target has increased from $5.75 to $6.31, reflecting a slightly improved near-term outlook as analysts cite cost controls and recent Buy ratings, even as revenue and margin expectations moderate. Analyst Commentary Recent analyst notes on CareCloud highlight both positive and cautious perspectives regarding the company’s outlook and valuation.CCLD: Improved Cost Controls Will Drive Higher Near-Term Profitability
CareCloud's analyst price target has been raised by $1.00 to $3.25, as analysts point to improved cost controls and a stable near-term earnings outlook following recent updates to estimates. Analyst Commentary Following recent updates, analysts have offered perspectives highlighting both the positive developments and ongoing concerns for CareCloud.There's No Escaping CareCloud, Inc.'s (NASDAQ:CCLD) Muted Revenues Despite A 30% Share Price Rise
Despite an already strong run, CareCloud, Inc. ( NASDAQ:CCLD ) shares have been powering on, with a gain of 30% in the...There's No Escaping CareCloud, Inc.'s (NASDAQ:CCLD) Muted Revenues Despite A 33% Share Price Rise
Those holding CareCloud, Inc. ( NASDAQ:CCLD ) shares would be relieved that the share price has rebounded 33% in the...CirrusAI, Series Conversion And Acquisition Reentry Will Unlock New Opportunities
AI-driven solutions and innovations, including CirrusAI, position CareCloud for enhanced revenue growth and new market opportunities.Analysts Have Been Trimming Their CareCloud, Inc. (NASDAQ:CCLD) Price Target After Its Latest Report
There's been a notable change in appetite for CareCloud, Inc. ( NASDAQ:CCLD ) shares in the week since its annual...Not Many Are Piling Into CareCloud, Inc. (NASDAQ:CCLD) Stock Yet As It Plummets 65%
CareCloud, Inc. ( NASDAQ:CCLD ) shareholders won't be pleased to see that the share price has had a very rough month...CareCloud (NASDAQ:CCLD) Is Looking To Continue Growing Its Returns On Capital
What are the early trends we should look for to identify a stock that could multiply in value over the long term...The Market Doesn't Like What It Sees From CareCloud, Inc.'s (NASDAQ:CCLD) Revenues Yet As Shares Tumble 25%
CareCloud, Inc. ( NASDAQ:CCLD ) shares have retraced a considerable 25% in the last month, reversing a fair amount of...CareCloud, Inc. (NASDAQ:CCLD) Shares Fly 34% But Investors Aren't Buying For Growth
CareCloud, Inc. ( NASDAQ:CCLD ) shareholders have had their patience rewarded with a 34% share price jump in the last...We Think CareCloud (NASDAQ:CCLD) Has A Fair Chunk Of Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...CareCloud, Inc. (NASDAQ:CCLD) Shares Fly 25% But Investors Aren't Buying For Growth
CareCloud, Inc. ( NASDAQ:CCLD ) shares have had a really impressive month, gaining 25% after a shaky period beforehand...CareCloud, Inc. (NASDAQ:CCLD) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough
CareCloud, Inc. ( NASDAQ:CCLD ) shares have retraced a considerable 26% in the last month, reversing a fair amount of...We Think CareCloud (NASDAQ:CCLD) Has A Fair Chunk Of Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...CareCloud, Inc. (NASDAQ:CCLD) Held Back By Insufficient Growth Even After Shares Climb 158%
CareCloud, Inc. ( NASDAQ:CCLD ) shareholders would be excited to see that the share price has had a great month...CareCloud, Inc. (NASDAQ:CCLD) Shares Could Be 42% Below Their Intrinsic Value Estimate
Key Insights CareCloud's estimated fair value is US$1.92 based on 2 Stage Free Cash Flow to Equity CareCloud is...The Market Doesn't Like What It Sees From CareCloud, Inc.'s (NASDAQ:CCLD) Revenues Yet As Shares Tumble 27%
CareCloud, Inc. ( NASDAQ:CCLD ) shareholders that were waiting for something to happen have been dealt a blow with a...Little Excitement Around CareCloud, Inc.'s (NASDAQ:CCLD) Revenues As Shares Take 25% Pounding
The CareCloud, Inc. ( NASDAQ:CCLD ) share price has softened a substantial 25% over the previous 30 days, handing back...Is CareCloud (NASDAQ:CCLD) Using Too Much Debt?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...CareCloud, Inc.'s (NASDAQ:CCLD) 31% Dip In Price Shows Sentiment Is Matching Revenues
CareCloud, Inc. ( NASDAQ:CCLD ) shareholders that were waiting for something to happen have been dealt a blow with a...Is CareCloud (NASDAQ:CCLD) A Risky Investment?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Things Look Grim For CareCloud, Inc. (NASDAQ:CCLD) After Today's Downgrade
Today is shaping up negative for CareCloud, Inc. ( NASDAQ:CCLD ) shareholders, with the analysts delivering a...There's No Escaping CareCloud, Inc.'s (NASDAQ:CCLD) Muted Revenues
With a price-to-sales (or "P/S") ratio of 0.4x CareCloud, Inc. ( NASDAQ:CCLD ) may be sending very bullish signals at...CareCloud, Inc. (NASDAQ:CCLD) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Last week, you might have seen that CareCloud, Inc. ( NASDAQ:CCLD ) released its first-quarter result to the market...決済の安定と成長
配当データの取得
安定した配当: CCLDの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。
増加する配当: CCLDの配当金が増加しているかどうかを判断するにはデータが不十分です。
配当利回り対市場
| CareCloud 配当利回り対市場 |
|---|
| セグメント | 配当利回り |
|---|---|
| 会社 (CCLD) | n/a |
| 市場下位25% (US) | 1.4% |
| 市場トップ25% (US) | 4.3% |
| 業界平均 (Healthcare Services) | 1.3% |
| アナリスト予想 (CCLD) (最長3年) | n/a |
注目すべき配当: CCLDは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。
高配当: CCLDは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。
株主への利益配当
収益カバレッジ: CCLDの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。
株主配当金
キャッシュフローカバレッジ: CCLDが配当金を報告していないため、配当金の持続可能性を計算できません。
高配当企業の発掘
企業分析と財務データの現状
| データ | 最終更新日(UTC時間) |
|---|---|
| 企業分析 | 2026/05/20 05:45 |
| 終値 | 2026/05/20 00:00 |
| 収益 | 2026/03/31 |
| 年間収益 | 2025/12/31 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM(Trailing Twelve Month)またはLTM(Last Twelve Month)データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。
シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
CareCloud, Inc. 4 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。8
| アナリスト | 機関 |
|---|---|
| Marc Wiesenberger | B. Riley Securities, Inc. |
| Keay Nakae | Chardan Capital Markets, LLC |
| Eugene Mannheimer | Colliers Securities |